Berkshire sells $183M of own stock near 52-week low

Berkshire Hathaway insiders sold $182.9M of BRK.B this week. Discretionary. Not a pre-planned sale, and they unloaded 4.1% of their position while the stock sat at $465.52, just 6% off its 52-week high of $521. This is the company where Greg Abel, Buffett's successor, just sent what one outlet called a "$397 billion warning" to investors.

Here's what makes it land differently: Berkshire is the house that preaches long-term holding. When insiders at the company built on not selling decide to sell, the gap between the message and the move is the story. The stock is flat year-to-date while the market climbed. They sold anyway.

Loews director adds $527K near all-time highs

Board member Robusto bought $527K of L at $105, near the 52-week high of $115. Discretionary purchase, not pre-planned. He just increased his stake by 49% while the stock trades flat on the year after a 24% run from its low. Insiders don't typically chase highs without reason.

WTW CEO buys $510K in open market near 52-week low

Board member Hess just put $510K into WTW at $260, a discretionary buy near the bottom of its 52-week range. The stock has been dead money this year while peers rallied, pressured by the DOJ challenging its $30B Aon merger back in 2021. His timing looks calculated: buying the dip after a 26% drop from the March peak.

Clorox director buys $429K at 52-week low amid margin recovery

Board member Breber dropped $429K into Clorox at $86, the 52-week low. This discretionary buy added 21.7% to his position as the stock sits flat for the year after getting hammered from its $139 peak. Insiders buying at multi-year lows while everyone else is frozen.

Alexandria chairman buys $410K near 5-year lows

Board member Marcus just bought $410K of ARE at $44, a discretionary purchase near the 52-week low of $39. The stock is down 50% from its peak as life science real estate faces funding headwinds. He added 1.7% to his position while the sector bleeds.

CAT director buys $219K at all-time high after flat year

Board member MacLennan bought $219K of CAT at $904, just below the all-time high of $905. Discretionary purchase, not pre-planned. The stock has tripled from its 52-week low while delivering double Nvidia's returns, yet he's adding at the peak as infrastructure spending debates heat up.

Executive Chairman dumps $21.5M REG at 52-week highs

Regency Centers CEO Martin Stein just unloaded $21.5M in stock at $78.75, less than 4% from the 52-week high. Discretionary, not pre-planned. REG operates shopping centers anchored by grocery stores, which typically hold steady in downturns but struggle to generate much upside in flat retail environments.

Hubbell enters material agreement, issues Reg FD disclosure

Hubbell filed a four-item 8-K covering a material agreement, a Reg FD disclosure, and supplemental exhibits. The company disclosed something enough to warrant immediate public notice rather than waiting for the next quarterly report. HUBB trades near the middle of its 52-week range at $508, flat for the year.

CBRE taps credit markets with new $3B revolving facility

CBRE just locked in $3 billion of credit through a new five-year revolving facility, replacing its existing arrangement. The commercial real estate giant is refinancing while rates stabilize and before any market disruptions hit. With the stock down 18% from its 52-week high, the company is securing flexibility to fund acquisitions or weather a commercial real estate downturn.

Market Context